Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -11.23% is in line with its 5-year average of -10.97%, around the middle of its 5-year range (-29.21%–-0.73%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.46% above its 12-month average of -20.22%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -0.32%.
RETURN ON ASSETS (ROA)
-11.23%
RETURN ON ASSETS (ROA) AVG TTM
-20.22%
RETURN ON ASSETS (ROA) AVG 3Y
-14.66%
RETURN ON ASSETS (ROA) AVG 5Y
-10.97%
RETURN ON ASSETS (ROA) AVG 10Y
-19.55%
RETURN ON ASSETS (ROA) AVG 15Y
-33.83%
RETURN ON ASSETS (ROA) AVG 20Y
-41.43%
CURRENT VS TTM AVG
+44.46%
CURRENT VS 3Y AVG
+23.37%
CURRENT VS 5Y AVG
-2.37%
CURRENT VS 10Y AVG
+42.57%
CURRENT VS 15Y AVG
+66.80%
CURRENT VS 20Y AVG
+72.90%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 855 covered companies
CURRENT VS SECTOR MEDIAN
+65.17%
vs the sector median at left
Precision Optics Corporation, Inc.
Market Cap
$48.05M
Return on Assets (ROA)
-11.23%
TTM Avg
-20.22%
3Y Avg
-14.66%
5Y Avg
-10.97%
Market Cap
$48.15M
Return on Assets (ROA)
-166.66%
TTM Avg
-126.93%
3Y Avg
-59.31%
5Y Avg
-48.60%
Market Cap
$47.41M
Return on Assets (ROA)
-15.32%
TTM Avg
-31.60%
3Y Avg
-39.35%
5Y Avg
-32.49%
Market Cap
$48.90M
Return on Assets (ROA)
-71.66%
TTM Avg
-64.58%
3Y Avg
-65.51%
5Y Avg
-55.75%
Market Cap
$49.21M
Return on Assets (ROA)
-68.93%
TTM Avg
-45.51%
3Y Avg
-54.02%
5Y Avg
-50.43%
Market Cap
$49.55M
Return on Assets (ROA)
-37.53%
TTM Avg
-1.93%
3Y Avg
9.94%
5Y Avg
4.69%
Market Cap
$49.58M
Return on Assets (ROA)
-68.60%
TTM Avg
-124.17%
3Y Avg
-83.59%
5Y Avg
-65.75%
Market Cap
$49.67M
Return on Assets (ROA)
-22.27%
TTM Avg
-102.93%
3Y Avg
-118.23%
5Y Avg
-95.88%
Market Cap
$50.56M
Return on Assets (ROA)
-97.71%
TTM Avg
-228.91%
3Y Avg
-360.64%
5Y Avg
-295.62%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision Optics Corporation, Inc. (POCI) | $48.05M | -11.23% | -20.22% | -14.66% | -10.97% |
| Lite Strategy, Inc. (LITS)vs › | $48.15M | -166.66% | -126.93% | -59.31% | -48.60% |
| Instil Bio, Inc. (TIL)vs › | $47.41M | -15.32% | -31.60% | -39.35% | -32.49% |
| Celularity Inc. (CELU)vs › | $48.90M | -71.66% | -64.58% | -65.51% | -55.75% |
| TELA Bio, Inc. (TELA)vs › | $49.21M | -68.93% | -45.51% | -54.02% | -50.43% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | -37.53% | -1.93% | 9.94% | 4.69% |
| INmune Bio, Inc. (INMB)vs › | $49.58M | -68.60% | -124.17% | -83.59% | -65.75% |
| Microbot Medical Inc. (MBOT)vs › | $49.67M | -22.27% | -102.93% | -118.23% | -95.88% |
| Envoy Medical, Inc. (COCH)vs › | $50.56M | -97.71% | -228.91% | -360.64% | -295.62% |
| Apollomics, Inc. (APLM)vs › | $49.19M | -162.93% | -287.06% | -300.16% | -220.25% |
ROA
-11.2%
ROE
-17.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -11.23% |
| 2025-06-30 | -29.21% |
| 2024-06-30 | -17.45% |
| 2023-06-30 | -0.73% |
| 2022-06-30 | -5.56% |
| 2021-06-30 | -1.64% |
| 2020-06-30 | -22.45% |
| 2019-06-30 | -8.21% |
| 2018-06-30 | -13.99% |
| 2017-06-30 | -55.89% |
| 2016-06-30 | -48.74% |
| 2015-06-30 | -57.73% |
| 2014-06-30 | -63.20% |
| 2013-06-30 | -77.62% |
| 2012-06-30 | 77.10% |
| 2011-06-30 | -93.75% |
| 2010-06-30 | -34.27% |
| 2009-06-30 | -50.23% |
| 2008-06-30 | -71.15% |
| 2007-06-30 | -95.20% |
| 2006-06-30 | -70.39% |
| 2005-06-30 | -109.49% |
| 2004-06-30 | -175.66% |
| 2003-06-30 | -51.15% |
| 2002-06-30 | -112.31% |
| 2001-06-30 | -19.47% |
| 2000-06-30 | -10.73% |
| 1999-06-30 | -51.52% |
| 1998-06-30 | -39.22% |
| 1997-06-30 | -6.67% |
